Published in BMC Public Health on December 12, 2005
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet (2009) 6.96
Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med (2007) 2.88
Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One (2009) 2.42
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci U S A (2006) 2.00
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65
How can mathematical models advance tuberculosis control in high HIV prevalence settings? Int J Tuberc Lung Dis (2014) 1.49
The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One (2008) 1.48
Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bull World Health Organ (2007) 1.43
International Monetary Fund programs and tuberculosis outcomes in post-communist countries. PLoS Med (2008) 1.41
Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol (2008) 1.31
Synthesizing epidemiological and economic optima for control of immunizing infections. Proc Natl Acad Sci U S A (2011) 1.27
HIV spending as a share of total health expenditure: an analysis of regional variation in a multi-country study. PLoS One (2010) 1.23
Long delays and missed opportunities in diagnosing smear-positive pulmonary tuberculosis in Kampala, Uganda: a cross-sectional study. PLoS One (2010) 1.20
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J (2015) 1.18
Comparative cost-effectiveness analysis of two MSF surgical trauma centers. World J Surg (2010) 1.14
Putting health metrics into practice: using the disability-adjusted life year for strategic decision making. BMC Public Health (2013) 1.10
Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study. PLoS One (2012) 1.01
The role of mathematical modelling in guiding the science and economics of malaria elimination. Int Health (2010) 0.92
Epidemiological models of Mycobacterium tuberculosis complex infections. Math Biosci (2012) 0.91
Periodic active case finding for TB: when to look? PLoS One (2011) 0.90
Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa. PLoS One (2015) 0.88
Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics. Proc Natl Acad Sci U S A (2013) 0.86
Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. J R Soc Interface (2015) 0.81
A metapopulation model of tuberculosis transmission with a case study from high to low burden areas. PLoS One (2012) 0.81
Models of latent tuberculosis: their salient features, limitations, and development. J Lab Physicians (2011) 0.81
Tuberculosis in resource poor countries. BMJ (2007) 0.79
Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana. J Acquir Immune Defic Syndr (2015) 0.79
Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa. PLoS One (2016) 0.77
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet (1995) 21.03
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet (2002) 6.47
Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis (2005) 4.96
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS (2004) 4.64
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet (2004) 3.14
Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ (2002) 3.03
Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science (2003) 2.83
Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ (2002) 2.31
Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Bull World Health Organ (1998) 2.23
Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS (1999) 2.11
Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS (2003) 2.11
Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans R Soc Trop Med Hyg (1998) 1.89
Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis (2003) 1.79
Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention. Lancet (2004) 1.66
Low access to a highly effective therapy: a challenge for international tuberculosis control. Bull World Health Organ (2002) 1.53
Costs and effectiveness--the impact of economic studies on TB control. Tuberculosis (Edinb) (2003) 1.14
The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia. J Trop Med Hyg (1995) 1.13
Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence. Int J Tuberc Lung Dis (2002) 1.07
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet (2010) 7.07
Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet (2002) 6.47
Tuberculosis. Lancet (2003) 6.39
Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 5.93
Global incidence of multidrug-resistant tuberculosis. J Infect Dis (2006) 5.42
The international Ebola emergency. N Engl J Med (2014) 5.35
The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis (2003) 5.09
The population dynamics and control of tuberculosis. Science (2010) 5.08
Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (2003) 4.87
Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years. Trop Med Int Health (2003) 4.29
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ (2011) 4.19
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature (2006) 3.72
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet (2002) 3.67
Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One (2011) 3.57
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44
Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health (2008) 3.32
Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med (2004) 3.26
Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ (2002) 3.03
Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines. PLoS Med (2006) 2.99
Tuberculosis incidence in prisons: a systematic review. PLoS Med (2010) 2.96
West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96
AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS (2009) 2.92
Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet (2012) 2.83
Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science (2003) 2.83
HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis (2006) 2.82
Impact of malaria control on childhood anaemia in Africa -- a quantitative review. Trop Med Int Health (2004) 2.80
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A (2009) 2.78
Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med (2011) 2.74
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science (2002) 2.65
Prospects for tuberculosis elimination. Annu Rev Public Health (2012) 2.50
Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ (2005) 2.50
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis (2003) 2.49
MDR tuberculosis--critical steps for prevention and control. N Engl J Med (2010) 2.49
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis (2006) 2.48
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J (2012) 2.47
Tuberculosis control in the era of HIV. Nat Rev Immunol (2005) 2.40
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics (2012) 2.36
Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis (2002) 2.33
A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol (2009) 2.20
Ebola virus disease in the Democratic Republic of Congo. N Engl J Med (2014) 2.19
Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17
Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS (2003) 2.11
Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data. Lancet (2013) 2.03
Eliminating human tuberculosis in the twenty-first century. J R Soc Interface (2008) 2.00
Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis (2002) 1.97
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis (2013) 1.96
Spatial analysis of tuberculosis cases in migrants and permanent residents, Beijing, 2000-2006. Emerg Infect Dis (2008) 1.91
Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis (2012) 1.81
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
What is the limit to case detection under the DOTS strategy for tuberculosis control? Tuberculosis (Edinb) (2003) 1.72
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J (2012) 1.70
Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007. BMC Infect Dis (2010) 1.67
Global epidemiology of tuberculosis. Semin Respir Crit Care Med (2013) 1.66
Ebola vaccine--an urgent international priority. N Engl J Med (2014) 1.66
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One (2008) 1.61
Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bull World Health Organ (2009) 1.59
Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One (2011) 1.51
Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc (2010) 1.51
Preventing HIV transmission with antiretrovirals. Bull World Health Organ (2009) 1.50
The development and impact of tuberculosis vaccines. Cell (2006) 1.50
Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A (2010) 1.48
High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr (2002) 1.43
Global burden and epidemiology of tuberculosis. Clin Chest Med (2009) 1.35
The unexplored story of HIV and ageing. Bull World Health Organ (2009) 1.34
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ (2012) 1.27
Controlling the last known cluster of Ebola virus disease - Liberia, January-February 2015. MMWR Morb Mortal Wkly Rep (2015) 1.22